Data for: Validity of targeted next generation sequencing in routine care for identifying clinically relevant molecular profiles in non-small cell lung cancer: results of a 2 years experience on 1343 samples

Name: Data for: Validity of targeted next generation sequencing in routine care for identifying clinically relevant molecular profiles in non-small cell lung cancer: results of a 2 years experience on 1343 samples
Creator: helene blons
Published: 2018-08-29T14:00:43.322Z
Keywords: Molecular Biology, Lung Cancer

blons, helene; Barritault, Marc; Giraudet, Véronique; Julie, Catherine; Digan, William; Cazier, Alain; Pastre, Jean; Gibault, Laure; Guyard, Alice; Rance, Bastien; Laurent-Puig, Pierre; Fabre, Elizabeth; Jouveshomme, Stéphane; Tallet, Anne; Pecuchet, Nicolas; Duchatelle, Véronique; Le Pimpec-Barthes, Françoise; Legras, Antoine; Giroux Leprieur, Etienne

doi:10.17632/4vmd7bxdct.1

Data for: Validity of targeted next generation sequencing in routine care for identifying clinically relevant molecular profiles in non-small cell lung cancer: results of a 2 years experience on 1343 samples

Published: 29 August 2018| Version 1 | DOI: 10.17632/4vmd7bxdct.1

Contributors:

helene blons, Marc Barritault, Véronique Giraudet, Catherine Julie, William Digan, Alain Cazier, Jean Pastre, Laure Gibault, Alice Guyard, Bastien Rance, Pierre Laurent-Puig, Elizabeth Fabre, Stéphane Jouveshomme, Anne Tallet, Nicolas Pecuchet, Véronique Duchatelle, Françoise Le Pimpec-Barthes, Antoine Legras, Etienne Giroux Leprieur

Description

1343 NSCLC patients. Molecular diagnosis, CAST vs NGS. Description of molecular alterations (alterations associations, identifications of new actionable targets) using NGS.

Data for: Validity of targeted next generation sequencing in routine care for identifying clinically relevant molecular profiles in non-small cell lung cancer: results of a 2 years experience on 1343 samples

Description

Files

Categories

Licence